Medeze Group PCL
Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number… Read more
Market Cap & Net Worth: Medeze Group PCL (MEDEZE)
Medeze Group PCL (BK:MEDEZE) has a market capitalization of $192.50 Million (฿6.67 Billion) as of March 18, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #21824 globally and #250 in its home market, demonstrating a 2.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medeze Group PCL's stock price ฿6.25 by its total outstanding shares 1068000000 (1.07 Billion).
Medeze Group PCL Market Cap History: 2024 to 2026
Medeze Group PCL's market capitalization history from 2024 to 2026. Data shows growth from $274.12 Million to $192.50 Million (0.00% CAGR).
Medeze Group PCL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medeze Group PCL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MEDEZE by Market Capitalization
Companies near Medeze Group PCL in the global market cap rankings as of March 18, 2026.
Key companies related to Medeze Group PCL by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #271 globally with a market cap of $77.08 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1068 globally with a market cap of $18.32 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1227 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | HCA Holdings Inc | NYSE:HCA | $77.08 Billion | $509.87 |
| #1068 | Tenet Healthcare Corporation | NYSE:THC | $18.32 Billion | $211.64 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1227 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
Medeze Group PCL Historical Marketcap From 2024 to 2026
Between 2024 and today, Medeze Group PCL's market cap moved from $274.12 Million to $ 192.50 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿192.50 Million | -1.57% |
| 2025 | ฿195.58 Million | -28.65% |
| 2024 | ฿274.12 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Medeze Group PCL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $192.50 Million USD |
| MoneyControl | $192.50 Million USD |
| MarketWatch | $192.50 Million USD |
| marketcap.company | $192.50 Million USD |
| Reuters | $192.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.